144 related articles for article (PubMed ID: 32850975)
1. Inhibition of the SET8 Pathway Ameliorates Lung Fibrosis Even Through Fibroblast Dedifferentiation.
Ugai K; Matsuda S; Mikami H; Shimada A; Misawa T; Nakamura H; Tatsumi K; Hatano M; Murayama T; Kasuya Y
Front Mol Biosci; 2020; 7():192. PubMed ID: 32850975
[TBL] [Abstract][Full Text] [Related]
2. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis.
Suzuki K; Kim JD; Ugai K; Matsuda S; Mikami H; Yoshioka K; Ikari J; Hatano M; Fukamizu A; Tatsumi K; Kasuya Y
Mol Med Rep; 2020 Aug; 22(2):1518-1526. PubMed ID: 32626975
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α.
Yamazaki R; Kasuya Y; Fujita T; Umezawa H; Yanagihara M; Nakamura H; Yoshino I; Tatsumi K; Murayama T
FASEB J; 2017 Aug; 31(8):3359-3371. PubMed ID: 28446589
[TBL] [Abstract][Full Text] [Related]
6. Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution.
Zhang Y; Fu J; Li C; Chang Y; Li X; Cheng H; Qiu Y; Shao M; Han Y; Feng D; Yue S; Sun Z; Luo Z; Zhou Y
Cell Mol Life Sci; 2023 Sep; 80(10):308. PubMed ID: 37768341
[TBL] [Abstract][Full Text] [Related]
7. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
8. Psoralen attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting myofibroblast activation and collagen deposition.
Du MY; Duan JX; Zhang CY; Yang HH; Guan XX; Zhong WJ; Liu YZ; Li ZM; Cheng YR; Zhou Y; Guan CX
Cell Biol Int; 2020 Jan; 44(1):98-107. PubMed ID: 31329322
[TBL] [Abstract][Full Text] [Related]
9. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
11. Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging.
Kato K; Logsdon NJ; Shin YJ; Palumbo S; Knox A; Irish JD; Rounseville SP; Rummel SR; Mohamed M; Ahmad K; Trinh JM; Kurundkar D; Knox KS; Thannickal VJ; Hecker L
Am J Respir Cell Mol Biol; 2020 May; 62(5):633-644. PubMed ID: 31962055
[TBL] [Abstract][Full Text] [Related]
12. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
[TBL] [Abstract][Full Text] [Related]
13. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
Sontake V; Kasam RK; Sinner D; Korfhagen TR; Reddy GB; White ES; Jegga AG; Madala SK
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135315
[TBL] [Abstract][Full Text] [Related]
15. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung.
Sava P; Ramanathan A; Dobronyi A; Peng X; Sun H; Ledesma-Mendoza A; Herzog EL; Gonzalez AL
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263297
[TBL] [Abstract][Full Text] [Related]
16. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
18. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
[TBL] [Abstract][Full Text] [Related]
19. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
20. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
